Argenx
ARGX
#484
Rank
HK$399.80 B
Marketcap
HK$6,461
Share price
-2.15%
Change (1 day)
32.81%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Half-year Reports

Thumbnail Argenx
 Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail Argenx
 Half-year Report 2024-h1

Half-year Report 2024-h1

Language: English

View Half-year Report
Thumbnail Argenx
 Half-year Report 2023-h1

Half-year Report 2023-h1

Language: English

View Half-year Report
Thumbnail Argenx
 Half-year Report 2022-h1

Half-year Report 2022-h1

Language: English

View Half-year Report
Thumbnail Argenx
 Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report
Thumbnail Argenx
 Half-year Report 2020-h1

Half-year Report 2020-h1

Language: English

View Half-year Report
Thumbnail Argenx
 Half-year Report 2019-h1

Half-year Report 2019-h1

Language: English

View Half-year Report